NCT06369168

Brief Summary

With this clinical trial we investigate whether auricular acupuncture during adjuvant endocrine therapy has an improving effect on hot flashes, which are often perceived as psychologically and physically stressful in self-assessment of women with breast cancer. Empirical studies indicate that body acupuncture has positive effects on hot flashes. As auricular acupuncture offers a number of advantages over body acupuncture, a three-armed randomised controlled research design is being used to investigate whether hot flashes caused by endocrine therapy are also reduced by ear acupuncture. Balanced ear acupuncture will be compared with NADA ear acupuncture in terms of efficacy and effectiveness. In addition, the effects of the two forms of therapy on the patients' individual quality of life, fatigue, stress perception and sleep quality will be analysed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
107

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 12, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 16, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

June 17, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 8, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 8, 2025

Completed
Last Updated

December 15, 2025

Status Verified

August 1, 2025

Enrollment Period

1.2 years

First QC Date

April 12, 2024

Last Update Submit

December 6, 2025

Conditions

Keywords

breast cancerhot flashesacupunctureendocrine therapy

Outcome Measures

Primary Outcomes (1)

  • subscale somato-vegetative symptoms of the Menopause Rating Scale (MRS)

    measure for hot flashes, from minimum 0 to maximum 4, with the maximum being the worst outcome

    Baseline, end of the intervention (6 weeks after the beginning), three months follow-up

Secondary Outcomes (9)

  • Menopause Rating Scale (MRS) total score

    Baseline, end of the intervention (6 weeks after the beginning), three months follow-up

  • Psychological symptoms and urogenital symptoms subscales of the MRS

    Baseline, end of the intervention (6 weeks after the beginning), three months follow-up

  • functional assessment of cancer therapy - breast (FACT-B)

    Baseline, end of the intervention (6 weeks after the beginning), three months follow-up

  • perceived stress questionnaire (PSQ)

    Baseline, end of the intervention (6 weeks after the beginning), three months follow-up

  • insomnia severity index (ISI)

    Baseline, end of the intervention (6 weeks after the beginning), three months follow-up

  • +4 more secondary outcomes

Study Arms (3)

NADA auricular acupuncture

ACTIVE COMPARATOR

Patients in one intervention group are treated twice a week for five weeks with balanced ear acupuncture.The data sets of those subjects who received at least eight balanced ear acupuncture treatments will be compared with those who got NADA acupuncture and those who were not treated.

Device: auricular acupuncture

balanced auricular acupuncture

ACTIVE COMPARATOR

Patients in the other intervention group are treated twice a week for five weeks with NADA ear acupuncture. The data sets of those subjects who received at least eight NADA ear acupuncture treatments will be compared with those who got balanced ear acupuncture and those who were not treated.

Device: auricular acupuncture

wait list control

NO INTERVENTION

Control group: At the end of the 3-month follow-up, the patients in the control group received 10 ear acupuncture treatments in a group setting.

Interventions

two auricular acupuncture methods are compared with each other and with no treatment

NADA auricular acupuncturebalanced auricular acupuncture

Eligibility Criteria

Age18 Years - 75 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • histologically confirmed diagnosis of non-metastatic hormone receptor-positive breast CA (TNM stage I-III) under adjuvant endocrine therapy
  • hot flashes, measured with the MRS (Menopause Rating Scale)
  • willingness to participate in the study and signed informed consent

You may not qualify if:

  • ongoing or planned chemotherapy, radiotherapy, follow-up treatment or reconstructive plastic surgery during the study period
  • severe physical or psychopharmacologically treated psychiatric comorbidity, due to which a patient is unable to participate in the study
  • pregnancy
  • participation in other clinical trials with behavioural, psychological or complementary medicine, psychological or complementary medical interventions
  • regular use of barbiturates, antidepressants, abuse of drugs and/or alcohol
  • ongoing acupuncture treatment
  • lack of ability to complete the questionnaires independently
  • operations or infections in the area to be acupunctured

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Evang. Kliniken Essen-Mitte gGmbH

Essen, Essen, Germany

Location

Evang. Kliniken Essen-Mitte gGmbH

Essen, Germany

Location

MeSH Terms

Conditions

Hot FlashesBreast Neoplasms

Interventions

Acupuncture, Ear

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Acupuncture TherapyComplementary TherapiesTherapeuticsAuriculotherapy

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 12, 2024

First Posted

April 16, 2024

Study Start

June 17, 2024

Primary Completion

September 8, 2025

Study Completion

September 8, 2025

Last Updated

December 15, 2025

Record last verified: 2025-08

Locations